We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+16.06%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.88B
AUM Growth
+$967M
Cap. Flow
-$59.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
72.68%
Holding
127
New
5
Increased
26
Reduced
38
Closed
14

Sector Composition

Rank Sector Weight
1 Financials 22.43%
2 Consumer Discretionary 16.91%
3 Healthcare 14.47%
4 Consumer Staples 10.11%
5 Communication Services 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
101
Acadia Healthcare
ACHC
$2.6B
$1.57M 0.02%
53,712
PBYI icon
102
Puma Biotechnology
PBYI
$399M
$1.52M 0.02%
39,179
EQIX icon
103
Equinix
EQIX
$99.6B
$1.33M 0.02%
+2,940
New +$1.2M
ALL icon
104
Allstate
ALL
$70.9B
$1.27M 0.02%
13,537
WP
105
DELISTED
Worldpay, Inc.
WP
$1.23M 0.02%
10,869
GOOGL icon
106
Alphabet (Google) Class A
GOOGL
$4.09T
$1.02M 0.01%
17,380
ACRS icon
107
Aclaris Therapeutics
ACRS
$722M
$890K 0.01%
148,506
-4,448
-3% -$29.5K
FIS icon
108
Fidelity National Information Services
FIS
$23.7B
$713K 0.01%
6,311
SUPN icon
109
Supernus Pharmaceuticals
SUPN
$2.73B
$607K 0.01%
17,325
FSTX
110
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$547K 0.01%
13,025
AVY icon
111
Avery Dennison
AVY
$12.8B
$396K 0.01%
3,500
-3,000
-46% -$310K
HIND
112
Vyome Holdings
HIND
$14.5M
0
GPRK icon
113
GeoPark
GPRK
$612M
$309K ﹤0.01%
17,977
-7,136
-28% -$126K
ACAD icon
114
Acadia Pharmaceuticals
ACAD
$4.46B
-7,943
Closed -$128K
AGIO icon
115
Agios Pharmaceuticals
AGIO
$2.1B
-3,531
Closed -$163K
BLUE
116
DELISTED
bluebird bio
BLUE
-184
Closed -$236K
ESPR
117
DELISTED
Esperion Therapeutics
ESPR
-4,874
Closed -$224K
EXEL icon
118
Exelixis
EXEL
$14B
-13,446
Closed -$264K
KHC icon
119
Kraft Heinz
KHC
$32.8B
-21,583
Closed -$929K
LKQ icon
120
LKQ Corp
LKQ
$6.75B
-37,951
Closed -$900K
MCD icon
121
McDonald's
MCD
$193B
-3,972
Closed -$705K
META icon
122
Meta Platforms (Facebook)
META
$1.49T
-2,516,587
Closed -$330M
SNA icon
123
Snap-on
SNA
$21.4B
-5,030
Closed -$731K
SNDX icon
124
Syndax Pharmaceuticals
SNDX
$1.7B
-12,896
Closed -$57K
RDUS
125
DELISTED
Radius Health, Inc.
RDUS
-7,153
Closed -$118K

Similar funds

C WorldWide Group's Q1 2019 Portfolio in Review

As of Q1 2019, C WorldWide Group held 127 positions worth $7.88B, up 14% from $6.91B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group's Q1 2019 filing shows 5 new, 26 increased, 38 reduced and 14 closed positions. Its largest new stake was LivaNova: 83,163 shares worth $8.09M. The largest sale was Meta Platforms (Facebook), an estimated $330M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q1 2019 buy was LivaNova: 83,163 shares worth $8.09M.
  • C WorldWide Group added most to Microsoft in Q1 2019, an estimated $343M increase.
  • C WorldWide Group's biggest Q1 2019 reduction was Visa, cutting an estimated $15.4M.
  • C WorldWide Group fully exited Meta Platforms (Facebook) in Q1 2019, selling an estimated $330M.
  • C WorldWide Group's ten largest holdings make up 73% of its $7.88B portfolio in Q1 2019.
  • C WorldWide Group opened 5 new positions and closed 14 in Q1 2019.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $7.88B.

Based on C WorldWide Group's 13F filing for Q1 2019, filed 3 May 2019.